Life-threatening bronchial asthma in children: from predictors to prognosis
https://doi.org/10.21508/1027-4065-2021-66-2-29-34
Abstract
Life-threatening exacerbation of bronchial asthma can occur in patients with any severity of the disease. The selection of predictors of a fatal condition can help to identify the groups with high-risk of asthmatic status development. For the moment the traditional intensive care for asthmatic status has been supplemented with innovative approaches in respiratory support, bronchodilator therapy, and basic support for the patients after life-threatening asthma. The predictors of life-threatening bronchial asthma include rhinovirus infection, severe exacerbation in the anamnesis, fungal sensitization and age of patients. This condition increases the risk of repeated life-threatening exacerbations by 25%, and it requires a special approach to therapy and monitoring of patients at the outpatient stage. This review draws attention to modern approaches to the treatment of such patients in order to unify the management of children with asthmatic status in the Russian Federation.
References
1. GINA Difficult-to-treat & Severe Ashtma in adolescent and adult patients Diagnosis and management 2019 [Электронный ресурс]. Ссылка активна на 29.03.2020.URL: https://ginasthma.org
2. Brakema E.A., Tabyshova A., van der Kleij R.M.J.J., Sooronbaev T., Lionis C., Anastasaki M. et al. The socioeconomic burden of chronic lung disease in low-resource settings across the globe – an observational FRESH AIR study. Eurostat Respir Res 2019; 20(1): 291. DOI: 10.1186/s12931-019-1255-z
3. Husam A., Turner S. Severe asthma in children – a review of definitions, epidemiology, and treatment options in 2019. Pediatr Pulmonol 2019; 54(6): 778–787. DOI: 10.1002/ppul.24317
4. Craig S., Babl F.E., Dalziel S.R., Gray C., Powell C., Al Ansari K. Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study. Trials 2020; 21(1): 1–12. DOI: 10.1186/s13063-019-3785-6
5. Фурман Е.Г., Каржавина Л.И., Пономарева М.С., Хузина Е.А. Астматический статус в детском возрасте: клиническая практика и тактика ведения больных бронхиальной астмой. Доктор. Ру 2018; 11(155): 43–49. [Furman E.G., Karzhavina L.I., Ponomarjova M.S., Huzina E.A. Status Asthmaticus at an Early Age: Clinical Practice and Management of Patients with Bronchial Asthma. Doktor. Ru 2018; 11(155): 43–49. (in Russ.)] DOI: 10.31550/1727-2378-2018-155-11-43-49
6. Boeschoten Sh., de Hoog M., Kneyber M., Merkus P., Boehmer A., Buysse C. et al. Current practices in children with severe acute asthma across European PICUs: an ESPNIC survey. Eur J Pediatr 2020; 179: 455–461. DOI: 10.1007/s00431-019-03502-9
7. Menzies-Gow A., Bafadhel M., Busse W.W., Casale T.B., Kocks W.H.J., Ian D. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol 2020; 145: 757–765. DOI: 10.1016/j.jaci.2019.12.006
8. Barsky E.E., Giancola M.L., Baxi N.S., Gaffin M.J. A Practical Approach to Severe Asthma in Children. Ann Am Thorac Soc 2018; 4: 399–408. DOI: 10.1513/AnnalsATS.201708-637FR
9. Mcmurray A., Cunningham S., Fleming L. Defining Near Fatal asthma – an international eDelphi study. Eur Respir J 2019; 54: PA949. DOI: 10.1183/13993003.congress-2019.PA949
10. Bagnasco D., Folli Ch., Manfredi A., Menzella F., Caminati M., Paggiaro L.P. et al. Severe asthma: one disease many definitions. Eur Respir J 2019; 54: PA5060. DOI: 10.1183/13993003.congress-2019.PA5060
11. Agnihotri N.T., Saltoun C. Acute severe asthma (status asthmaticus). Allergy Asthma Proc 2019; 40(6): 406–409. DOI: 10.2500/aap.2019.40.4258
12. Kenyon N., Zeki A.A., Albertson E.T., Louie S. Definition of Critical Asthma Syndromes. Clin Rev Allergy Immunol 2015; 48(1): 1–6. DOI: 10.1007/s12016-013-8395-6
13. Greenberger P.A. Potentially (near) fatal asthma. Allergy Asthma Proc 2019; 40(6): 403–405. DOI: 10.2500/aap.2019.40.4257
14. Denlinger L.C., Heymann P., Lutter R., Gern J.E. Exacerbation-Prone Asthma. J Allergy Clin Immunol Pract 2020; 8(2): 474–482. DOI: 10.1016/j.jaip.2019.11.009
15. Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы, 2017. [Federal clinical guidelines for Bronchial asthma, 2017. Электронный ресурс https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/Бронхиальная%20астма%20дети%20СПР%20рубрикатор.v2_2017_обновление.pdf
16. Ross K.R., Gupta R., DeBoer M.D., Zein J., Phillips B.R., Mauger D.T. et al. Severe asthma during childhood and adolescence: A longitudinal study. J Allergy Clin Immunol 2019; 145(1): 140–146. DOI: 10.1016/j.jaci.2019.09.030
17. Kostakou E., Kaniaris E., Filiou E., Vasileiadis I., Katsaounou P., Tzortzaki E. et al. Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management. J Clin Med 2019; 8(9): 1283. DOI: 10.3390/jcm8091283
18. Adeli M., El-Shareif T., Hendaus M.A. Asthma exacerbation related to viral infections: An up to date summary. J Family Med Prim Care 2019; 8(9): 2753–2759. DOI: 10.4103/jfmpc.jfmpc_86_19
19. Гаймоленко И.Н., Петрова А.И., Дутова А.А., Марковский А.В. Бронхиальная обструкция при острых респираторных вирусных инфекциях у детей дошкольного возраста. Забайкальский медицинский вестник 2018; 2:77–82. [Gajmolenko I.N., Petrova A.I., Dutova A.A., Markovskij A.V. Bronchial obstruction in acute respiratory viral infections in preschool children. Zabaikal’skii medicinskii vestnik. 2018; 2:77–82. (in Russ.)]
20. Ritchie A.I., Jackson D.J., Edwards M.R., Johnston S.L. Airway epithelial orchestration of innate immune function in response to virus infection. A focus on asthma. Ann Am Thorac Soc 2016; 13: 55–63. DOI: 10.1513/AnnalsATS.201507-421MG
21. Fedele G., Schiavoni I., Nenna R., Pierangeli A., Frassanito A., Leone P. et al. Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with respiratory syncytial virus and human rhinovirus. Pediatr Allergy Immunol 2018; 29: 555–557. DOI: 10.1111/pai.12919
22. Hadebe S., Brombacher F. Environment and Host-Genetic Determinants in Early Development of Allergic Asthma: Contribution of Fungi. Front Immunol 2019; 10: 2696. DOI: 10.3389/fimmu.2019.02696
23. Barnes C. Fungi and atopy. Clin Rev Allergy Immunol 2019; 57(3): 439–448. DOI: 10.1007/s12016-019-08750-z
24. Ardura-Garcia C., Arias E., Hurtado P., Bonnett L.J., Sandoval C., Maldonado A. et al. Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study. Eur Respir J 2019; 54(5): 1802419. DOI: 10.1183/13993003.02419-2018
25. Ardura-Garcia C., Stolbrink M., Zaidi S., Cooper P.J., Blakey J.D. Predictors of repeated acute hospital attendance for asthma in children: A systematic review and meta-analysis. Pediatr Pulmonol 2018; 53(9): 1179–1192. DOI: 10.1002/ppul.24068
26. Cundiff K.M., Gerard J.M., Flood R.J. Critical Care Interventions for Asthmatic Patients Admitted From the Emergency Department to the Pediatric Intensive Care Unit. J Pediatric Emergency Care 2018; 34(6): 385–389. DOI: 10.1097/pec.0000000000001163
27. Deliu M., Fontanella S., Haider S., Sperrin M., Geifman N., Murray C. et al. Longitudinal trajectories of severe wheeze exacerbations from infancy to school age and their association with early-life risk factors and late asthma outcomes. Clin Exp Allergy 2020; 50(3): 315–324. DOI: 10.1111/cea.13553
28. Denlinger L.C., Phillips B.R., Ramratnam S., Ross K., Bhakta N.R., Cardet J.C. et al. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations. Am J Respir Crit Care Med 2017; 195(3): 302–313. DOI: 10.1164/rccm.201602-0419OC
29. Ильенкова Н.А., Степанова Л.В., Коноплева О.С., Алексеева О.В., Пастухова С.Ю. Астматический статус в педиатрической практике. Клинический случай. Пермский медицинский журнал 2019; 36 (4): 88–96. [Il’enkova N.A., Stepanova L.V., Konopleva O.S., Alekseeva O.V., Pastuhova S.Yu. Asthmatic status in pediatric practice. Clinical case. Permskii meditsinskii zhurnal 2019; 36(4): 88–96. (in Russ.)] DOI: 10.178l6/pmj36488-96
30. Ramsahai J.M., Hansbro Ph.M., Wark P.A.B. Mechanisms and Management of Asthma Exacerbations. Am J Respir Crit Care Med 2019; 4: 423–432. DOI: 10.1164/rccm.201810-1931CI
31. Stefan M., Nathanson B., Lagu T., Priya A., Pekow P., Steingrub J. Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation. Ann Am Thorac Soc 2016; 13(7): 1096–1104. DOI: 10.1513/AnnalsATS.201510-701OC
32. Rodrigo G.J., Castro-Rodriguez J.A. Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014; 112(1): 29–34. DOI: 10.1016/j.anai.2013.09.024
33. Pilar J., Modesto I. Alapont V., Lopez-Fernandez Y.M., Lopez-Macias O., Garcia-Urabayen D. et al. High-flow nasal cannula therapy versus non-invasive ventilation in children with severe acute asthma exacerbation: An observational cohort study. Med Intensiva 2017; 41(7): 418–424 DOI: 10.1016/j.medin.2017.01.001
34. Can F.K., Anil A.B., Anil M., Zengin N., Durak F., Alparslan C. et al. Predictive factors for the outcome of high flow nasal cannula therapy in a pediatric intensive care unit: Is the SpO2 /FiO2 ratio useful? J Crit Care 2018; 44: 436–444. DOI: 10.1016/j.jcrc.2017.09.003
35. Vutipongsatorn K., Fujitake E.A., Singh S. Extracorporeal membrane oxygenation in life-threatening asthma unresponsive to mechanical ventilation: a comparison of patient demographics and outcomes between a large London-based intensive care unit and an international registry. Clin Med 2019; 19(3): 19. DOI: 10.7861/clinmedicine.19-3s-s19
36. Medar S.S., Derespina K.R., Jakobleff W.A., Ushay M.H., Peek G.J. A winter to remember! Extracorporeal membrane oxygenation for life-threatening asthma in children: A case series and review of literature. Pediatr Pulmonol 2020; 55(2): E1–E4. DOI: 10.1002/ppul.24616
37. Vet N.J., de Winter B.C.M., Koninckx M., Boeschoten Sh. A., Boehmer A.L.M., Verhallen J.T. et al. Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus. Clinical Pharmacokinetics 2020; 59: 257–264. DOI: 10.1007/s40262-019-00811-y
38. Indinnimeo L., Chiappini E., del Giudice M. Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics. Ital J Pediatr 2018; 44(1): 46. DOI: 10.1186/s13052-018-0481-1
39. Vasileiadis I., Alevrakis E., Ampelioti S., Vagionas D., Rovina N., Koutsoukou A. Acid-Base Disturbances in Patients with Asthma: A Literature Review and Comments on Their Pathophysiology. J Clin Med 2019; 8(4): 563. DOI: 10.3390/jcm8040563
40. Iramain R., Castro Rodriguez J.A., Jara A., Cardozo L., Bogado N., Morinigo R. et al. Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial. Pediatr Pulmonol 2019; 54(4): 372–377. DOI: 10.1002/ppul.24244
41. O’Byrne P., Fabbri L.M., Pavord I.D., Papi A., Petruzzelli S., Lange P. Asthma progression and mortality: the role of inhaled corticosteroids. Eur Respir J 2019; 54: 1900491. DOI: 10.1183/13993003.00491-2019
42. McKeever T., Mortimer K., Wilson A., Walker S., Brightling C., Andrew Skeggs A. et al. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. N Engl J Med 2018; 378: 902–910. DOI: 10.1056/NEJMoa1714257
43. Ruth A., Laura J., Joseph Z.J. Dexamethasone Compared to Prednisone for the Treatment of Children With Acute Asthma Exacerbations. Pediatric Emergency Care 2018; 34 (1):53–58. DOI: 10.1097/PEC.0000000000001371
44. Lee S.Y., Won H.K., Kim B.K., Kim S.H., Chang Y.S., Cho S.H. et al. Identification of a key gene module associated with glucocorticoidinduced derangement in bone mineral density in patients with asthma. Sci Rep 2019; 9(1): 20133. DOI: 10.1038/s41598-019-56656-9
45. Bravo-Soto G.A., Harismendy C., Rojas P., Silva R., von Borries P.I. Dexamethasone as effective as other corticosteroids for acute asthma exacerbation in children? Medwave 2017; 17 (Suppl 2): e6931. DOI: 10.5867/medwave.2017.6931
46. Morikawa M., Hagiwara Y., Gibo K., Goto T., Watase H., Hasegawa K. Methylxanthine use for acute asthma in the emergency department in Japan: a multicenter observational study. Acute Med Surg 2019; 6(3): 279–286. DOI: 10.1002/ams2.408
47. Amnuaypattanapon K., Limjindaporn C., Srivilaithon W., Dasanadeba I. Characteristics and outcomes of treatment in status asthmaticus patients at emergency department. Asian Pac J Allergy Immunol 2019; 37(2): 87–93. DOI: 10.12932/AP-261217-0224
48. Le Conte Ph., Terzi N., Mortamet G., Abroug F., Carteaux G., Charasse C. et al. Management of severe asthma exacerbation: guidelines from the SociétéFrançaise de Médecined’Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies Ann Intensive Care 2019; 9: 115. Published online 2019 Oct 10. DOI: 10.1186/s13613-019-0584-x
49. Rower J.E., Liu X., Yu T., Mundorff M., Sherwin C.M.T., Johnson M.D. Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma. Eur J Clin Pharmacol 2017; 73: 325–331. DOI: 10.1007/s00228-016-2165-3
50. Knightly R., Milan S., Hughes R., Knopp-sihota J., Rowe B., Normansell R. et al. Inhaled magnesium sulfate in the treatment of acute asthma (Review) Cochrane Database Syst Rev 2017; 11(11): CD003898. DOI: 10.1002/14651858.CD003898.pub6
51. Graff D.M., Stevenson M.D., Berkenbosch J.W. Safety of prolonged magnesium sulfate infusions during treatment for severe pediatric status asthmaticus. Pediatr Pulmonol 2019; 54(12):1941–1947. DOI: org/10.1002/ppul.24499
52. Brittan M., Richardson T., Kenyon C., Sills M.R., Fieldston E., Hall M. et al. Association between Postdischarge Oral Corticosteroid Prescription Fills and Readmission in Children with Asthma. J Pediatr 2017; 180: 163–169.e1. DOI: 10.1016/j.jpeds.2016.09.034
53. Engelkes M., Janssens H.M., de Ridder M.A., Sturkenboom M.C., de Jongste J.C., Verhamme K.M. Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care. Respir Med 2016; 119: 48–54. DOI: 10.1016/j.rmed.2016.08.016
54. Jackson D.J., Bacharier L.B., Mauger D.T., Boehmer S., Beigelman A., Chmiel J.F. et al. Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. N Engl J Med 2018; 378: 891–901. DOI: 10.1056/NEJMoa1710988
55. Kirkland S.W., Cross E., Campbell S., Villa-Roel C., Rowe B.H. Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma. Cochrane Database Syst Rev 2018; 6: CD012629. DOI: 10.1002/14651858.CD012629.pub2
56. Hamelmann E., von Mutius E., Bush A., Szefler S.J. Addressing the risk domain in the long-term management of pediat- ric asthma. Pediatr Allergy Immunol 2019; 31(3): 233–242. DOI: 10.1111/pai.13175
57. Hamilton D., Lehman H. Asthma Phenotypes as a Guide for Current and Future Biologic Therapies. Clin Rev Allergy Immunol 2019; 59(2): 160–174. DOI: 10.1007/s12016-019-08760-x
58. Mavissakalian M., Brady S. The Current State of Biologic Therapies for Treatment of Refractory Asthma. Clin Rev Allergy Immunol 2020; 59(2): 195–207. DOI: 10.1007/s12016-020-08776-8
59. Kenyon C.C., Gruschow S.M., Quarshie W.O., Griffis H., Leach M.C., Zorc J.J. et al. Controller adherence following hospital discharge in high risk children: A pilot randomized trial of text message reminders. J Asthma 2019; 56(1): 95–103. DOI: 10.1080/02770903.2018.1424195
60. Фассахов Р.С. Легкая бронхиальная астма: от парадоксов к оптимизации терапии. Медицинский совет 2018; 15: 38–42. [Fassahov R.S. Mild bronchial asthma: from paradoxes to optimization of therapy. Meditsinskii sovet 2018; 15: 38– 42. (in Russ.)] DOI: 10.21518/2079-701X-2018-15-38-42
Review
For citations:
Potapova N.L. Life-threatening bronchial asthma in children: from predictors to prognosis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2021;66(2):29-34. (In Russ.) https://doi.org/10.21508/1027-4065-2021-66-2-29-34
Views:
810
Email this article 